GlassScriptPhysician profile
S Robert Rozbruch
NPI 1073520185
$157,658.51
in general payments reported to CMS, 2019-2025
10 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,104 · 2020: $98.97 · 2021: $110K · 2022: $7,440 · 2023: $6,339 · 2024: $13K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $33K · Food and Beverage: $1,253 · Consulting Fee: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $32,622.20 |
| Food and Beverage | $1,253.06 |
| Consulting Fee | $1,080.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $109,430.09 | 2021-2022 | |
| Globus Medical, INC. | $27,794.12 | 2023-2025 | Precice Intramedullary Limb Lengthening System, Precice® Intramedullary Limb Lengthening System, Distal Femur Plate System |
| Nuvasive Specialized Orthopedics, INC. | $14,805.67 | 2019-2023 | Precice Intramedullary Limb Lengthening System |
| Medical Device Business Services, INC. | $3,960.00 | 2022-2023 | Na |
| Stryker Corporation | $1,005.83 | 2019-2025 | T2 Alpha, Pangea, Mako |
| Orthofix Medical, INC. | $355.57 | 2025 | 7d Surgical System |
| Smith+Nephew, INC. | $141.51 | 2019 | |
| Depuy Synthes Sales INC. | $106.61 | 2022 | |
| My01 INC. | $34.26 | 2024 | My01 Continuous Compartmental Pressure Monitor |
| Paragon 28, INC. | $24.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw S Robert Rozbruch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.